Brief: Cymabay Appoints Harish Shantharam As CFO

CymaBay Therapeutics

15/05/2023 21:39

May 15 (Reuters) - Cymabay Therapeutics Inc  CBAY.O :
    * CYMABAY REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS AND
PROVIDES CORPORATE UPDATE
    * CYMABAY THERAPEUTICS INC - HARISH SHANTHARAM APPOINTED AS
CHIEF
FINANCIAL OFFICER
    * CYMABAY THERAPEUTICS INC - HELD $236.4 MILLION IN CASH,
CASH
EQUIVALENTS AND INVESTMENTS AS OF MARCH 31, 2023
    * CYMABAY THERAPEUTICS INC - BELIEVE CASH AND INVESTMENTS ON
HAND
ARE SUFFICIENT TO FUND CO'S OPERATING PLAN THROUGH Q3 OF 2024
    * CYMABAY THERAPEUTICS INC- QTRLY LOSS PER SHARE $0.29

Source text for Eikon:  ID:nGNX3qCF9Y 
Further company coverage:  CBAY.O 

 ((Reutersbriefs@thomsonreuters.com;))